BPQ24
BioPORTER® QuikEase™ Protein Delivery Kit
for intracellular delivery
Synonyma:
BioPORTER Kit, Protein Delivery Kit
Přihlásitk zobrazení cen stanovených pro organizaci a smluvních cen
About This Item
Doporučené produkty
Hledáte podobné produkty? Navštivte Průvodce porovnáváním produktů
General description
Contains 24 individual tubes of BioPORTER reagent
Application
BioPORTER® QuikEase™ Protein Delivery Kit has been used to deliver active granzyme B tagged with FITC into mouse neuroblastoma cell lines. Protein concentrations used for delivery were 6μg/ml which when stained for FITC-GrB yielded a 90% uptake rate.
BioPORTER® QuikEase™ Protein Delivery Kit has been used:
- for the delivery of single-chain antibody variable fragment (scFv) into HeLa cells
- for the transduction of QBI-293 cells with human Tau protein
- for the delivery of human granzyme B (GrB) in human cervical cancer cells
- for the delivery of epidermal fatty acid-binding protein (E-FABP) into nerve growth factor-differentiated PC12 cells (NGFDPC12)
The BioPORTER® QuikEase™ Protein Delivery Kit is the latest innovation in macromolecule delivery technology. It is a unique lipid-based formulation that allows for the intracellular delivery of proteins, peptides, and bioactive molecules such as enzymes and antibodies, into a broad range of cell types. The BioPORTER QuikEase kits contain individual tubes of the BioPORTER Reagent in a convenient, ready-to-use, single reaction format. Each tube contains sufficient material of the lyophilized BioPORTER Reagent to perform 1 reaction in a 6-well plate (or 35 mm dish), 4 reactions in a 24-well plate (or 16 mm wells), and 10 reactions in a 96-well plate.
Legal Information
BioPorter is a registered trademark of Gene Therapy Systems, Inc.
QuikEase is a trademark of Gene Therapy Systems, Inc.
Storage Class
10 - Combustible liquids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Vyberte jednu z posledních verzí:
Již tento produkt vlastníte?
Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.
Cancer vaccination drives Nanog-dependent evolution of tumor cells towards an immune-resistant and stem-like phenotype
Cancer Research, canres-ca3758 (2012)
E. coli expression of a soluble, active single-chain antibody variable fragment containing a nuclear localization signal
Protein Expression and Purification, 66(2), 172-180 (2009)
Journal of virology, 85(5), 2325-2332 (2010-12-24)
The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) is the only HSV-1 gene transcript abundantly expressed throughout latency. LAT null mutants have a significantly reduced reactivation phenotype. LAT's antiapoptosis activity is the major LAT factor involved in supporting
Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles
The Journal of Biological Chemistry, 286(17), 15317-15331 (2011)
Communications biology, 4(1), 613-613 (2021-05-23)
Aggregation of α-synuclein (α-syn) is closely linked to Parkinson's disease (PD) and the related synucleinopathies. Aggregates spread through the brain during the progression of PD, but the mechanism by which this occurs is still not known. One possibility is a
Náš tým vědeckých pracovníků má zkušenosti ve všech oblastech výzkumu, včetně přírodních věd, materiálových věd, chemické syntézy, chromatografie, analytiky a mnoha dalších..
Obraťte se na technický servis.